Literature DB >> 29045159

Cracking the Vaccine Code in Tuberculosis.

Maziar Divangahi1,2,3,4,5,6, Marcel A Behr1,2,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29045159     DOI： 10.1164/rccm.201707-1489PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  6 in total

1.  Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.

Authors:  Paul T Elkington; Adrian C Bateman; Gareth J Thomas; Christian H Ottensmeier
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 21.405

2.  Vaccination Strategies Against Mycobacterium tuberculosis: BCG and Beyond.

Authors:  Janez Ferluga; Hadida Yasmin; Sanjib Bhakta; Uday Kishore
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

Authors:  P Nahid; L G Jarlsberg; M Kato-Maeda; M R Segal; D H Osmond; S Gagneux; K Dobos; M Gold; P C Hopewell; D M Lewinsohn
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

4.  β-Glucan Induces Protective Trained Immunity against Mycobacterium tuberculosis Infection: A Key Role for IL-1.

Authors:  Simone J C F M Moorlag; Nargis Khan; Boris Novakovic; Eva Kaufmann; Trees Jansen; Reinout van Crevel; Maziar Divangahi; Mihai G Netea
Journal:  Cell Rep       Date:  2020-05-19       Impact factor: 9.423

5.  Pan-Genome Reverse Vaccinology Approach for the Design of Multi-Epitope Vaccine Construct against Escherichia albertii.

Authors:  Khurshid Jalal; Kanwal Khan; Diyar Ahmad; Ajmal Hayat; Zarrin Basharat; Muhammad Naseer Abbas; Saad Alghamdi; Mazen Almehmadi; Muhammad Umar Khayam Sahibzada
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

Review 6.  The Pathogenesis of Tuberculosis: The Early Infiltrate of Post-primary (Adult Pulmonary) Tuberculosis: A Distinct Disease Entity.

Authors:  Robert L Hunter
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.